Clinical Trial Update: NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating NH002-mediated sonoporation with chemotherapy for advanced pancreatic cancer is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis
• Pancreatic Adenocarcinoma

Drugs mentioned

• NH002

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pancreatic Adenocarcinoma Metastatic, Liver Metastasis | Phase 1 | Status: NOT_YET_RECRUITING